You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glucocorticoid Receptor

Showing 1 - 25 of 7,648
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)

Not yet recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • (no location specified)
Feb 2, 2023

PTSD Trial in San Francisco (CORT108297, Placebo)

Not yet recruiting
  • PTSD
  • San Francisco, California
    San Francisco VA Medical Center, San Francisco, CA
Jul 26, 2022

Adenovirus Infection, BK Virus Infection, Cytomegaloviral Infection Trial in Houston (Virus-specific Cytotoxic T-lymphocytes)

Recruiting
  • Adenovirus Infection
  • +6 more
  • Virus-specific Cytotoxic T-lymphocytes
  • Houston, Texas
    M D Anderson Cancer Center
Jan 6, 2023

MDD, Childhood Trauma Trial in Amsterdam (Mifepristone, Placebo)

Recruiting
  • Major Depressive Disorder
  • Childhood Trauma
  • Amsterdam, Noord-Holland, Netherlands
    Amsterdam UMC, location VUmc
Mar 17, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • San Francisco, California
    University of California San Francisco
Dec 19, 2022

Breast Cancer Trial in United States (Mifepristone, Placebo, Nab-Paclitaxel)

Active, not recruiting
  • Breast Cancer
  • Birmingham, Alabama
  • +4 more
Mar 14, 2022

Subclinical Cushing's Trial in Sheffield (Mifepristone)

Completed
  • Subclinical Cushing's
  • Sheffield, United Kingdom
    Sheffield Teaching Hospitals NHS Foundation Trust
Jan 22, 2021

Binge-Eating Disorder, Eating Disorders, Obesity Trial in Lahore (BED Questionnaire)

Completed
  • Binge-Eating Disorder
  • +4 more
  • BED Questionnaire
  • Lahore, Punjab, Pakistan
    Zainab Khan
Mar 7, 2021

C-myc Biomarker Study for Diabetic Foot Ulcers

Recruiting
  • Diabetes
  • +3 more
    • San Francisco, California
    • +5 more
    Mar 9, 2022

    Adrenal Insufficiency Trial in Hellerup

    Completed
    • Adrenal Insufficiency
      • Hellerup, Denmark
        Department of Internal medicine, Herlev & Gentofte Universtity H
      May 9, 2020

      Hypercortisolism Trial in Worldwide (relacorilant, Placebo)

      Recruiting
      • Hypercortisolism
      • Birmingham, Alabama
      • +50 more
      Dec 13, 2022

      Glucocorticoid Receptor SNPs in Receptor Function and Metabolic

      Completed
      • Glucose Homeostasis
      • +4 more
        • Research Triangle Park, North Carolina
          NIEHS Clinical Research Unit (CRU)
        Dec 3, 2019

        Cushing Syndrome Trial in Worldwide (Relacorilant, Placebo)

        Recruiting
        • Cushing Syndrome
        • Phoenix, Arizona
        • +68 more
        Nov 14, 2022

        Stress Response Trial (tDCS actif, tDCS Sham)

        Not yet recruiting
        • Stress Response
        • tDCS actif
        • tDCS Sham
        • (no location specified)
        Apr 20, 2023

        Alcohol Use Disorder Trial in Baltimore (Mifepristone, Placebo - Cap)

        Recruiting
        • Alcohol Use Disorder
        • Baltimore, Maryland
          Integrated Program for Substance Abuse Research
        Jan 5, 2023

        IgG4-related Disease With Eosinophilia Trial in Beijing (Prednisolone, Baricitinib)

        Recruiting
        • IgG4-related Disease With Eosinophilia
        • Beijing, Bejing, China
          Peking Union Medical College Hospital
        Mar 23, 2023

        Associated With Child Growth and Adiposity

        Recruiting
        • Obesity
        • Obesity, Infant
        • overweight/obesity
        • La Plata, Buenos Aires, Argentina
          Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr.
        Mar 22, 2023

        ST Elevation Myocardial Infarction, Inflammatory Response, Myocardial Reperfusion Injury Trial (Methylprednisolone, Isotonic

        Not yet recruiting
        • ST Elevation Myocardial Infarction
        • +3 more
        • (no location specified)
        Aug 4, 2022

        Solid Tumors Trial in United States (CORT125134 with nab-paclitaxel)

        Completed
        Has Results
        • Solid Tumors
        • Relacorilant with nab-paclitaxel
        • Scottsdale, Arizona
        • +3 more
        Nov 9, 2022

        Mild Cognitive Impairment, Alzheimer, Memory Impairment Trial in Baltimore (CORT108297, Placebo)

        Recruiting
        • Mild Cognitive Impairment
        • +2 more
        • Baltimore, Maryland
          Johns Hopkins School of Medicine
        Jun 21, 2022

        Asthma Trial in London (Placebos, Formoterol Inhalant Powder, Budesonide Powder)

        Completed
        Has Results
        • Asthma
        • Placebos
        • +3 more
        • London, United Kingdom
          Section of Airway Disease, Asthma Lab, Imperial College London,
        Sep 24, 2019

        Preterm Birth, Mother-Infant Interaction, Infant Development Trial in Cologne (skin-to-skin contact)

        Recruiting
        • Preterm Birth
        • +2 more
        • skin-to-skin contact
        • Cologne, Northrhine-westfalia, Germany
          University hospital of Cologne, Department of Neonatology
        Aug 4, 2023

        Lymphocytes of Polymyalgia Patients

        Completed
        • Polymyalgia Rheumatica
        • Blood samples before and after standard of care of polymyalgia rheumatica
        • (no location specified)
        Jan 11, 2023

        Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

        Not yet recruiting
        • Immune Thrombocytopenia
        • Treatment
        • Obinutuzumab Injection [Gazyva]
        • Tianjin, China
          Institute of Hematology and Blood Diseases Hospital, Chinese Aca
        Oct 17, 2023

        Glomerulonephritis Rapidly Progressive Trial (ALE.F02, Rituximab, GlucoCorticoid)

        Not yet recruiting
        • Glomerulonephritis Rapidly Progressive
        • ALE.F02
        • +5 more
        • (no location specified)
        Sep 14, 2023